[Form 4] 60 DEGREES PHARMACEUTICALS, INC. Insider Trading Activity

Rhea-AI Filing Summary

Geoffrey S. Dow, President and CEO and a director of 60 Degrees Pharmaceuticals, Inc. (SXTP), reported an open-market purchase of company common stock on September 12, 2025. He acquired 7,201 shares at a reported price of $1.3881 per share. Following the transaction, Mr. Dow directly beneficially owns 33,372 shares and indirectly beneficially owns 11,119 shares through the Geoffrey S. Dow Revocable Trust, of which he is trustee and retains voting and dispositive control.

Positive

• Open-market purchase disclosed: 7,201 shares acquired on 09/12/2025 at $1.3881 per share.
• Complete ownership disclosure: Direct ownership of 33,372 shares and indirect ownership of 11,119 shares through the Geoffrey S. Dow Revocable Trust.
• Filing identifies roles: Reporting person is listed as President and CEO and a director, clarifying insider status.

Negative

• None.

Insights

Securities Analyst

TL;DR: CEO/director made a routine open-market purchase of 7,201 shares at $1.3881; total direct and indirect holdings are disclosed.

The Form 4 documents a single non-derivative open-market acquisition on 09/12/2025. The price and share count are explicitly reported, and the filing clarifies indirect ownership via a revocable trust where Mr. Dow is trustee with voting and dispositive power. This is a standard Section 16 disclosure that updates investors on insider ownership levels; the filing does not include any derivative transactions, sales, or other material events beyond the purchase.

Corporate Governance Expert

TL;DR: Disclosure is complete for the reported purchase and trust arrangement; no governance concerns flagged by the filing itself.

The Form 4 identifies Mr. Dow's roles as President, CEO and director and discloses both direct and indirect holdings post-transaction. It also states he is trustee of the Geoffrey S. Dow Revocable Trust and has control over those trust shares. The filing appears to follow Section 16 reporting requirements and contains a manual signature dated 09/15/2025. There are no indications of amendments or additional compensatory awards in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

DOW GEOFFREY S

(Last) (First) (Middle)

C/O 60 DEGREES PHARMACEUTICALS, INC.

1025 CONNECTICUT AVENUE NW SUITE 1000

(Street)

WASHINGTON DC 20036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
60 DEGREES PHARMACEUTICALS, INC. [ SXTP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2025		A		7,201	A	$1.3881	33,372(2)	D
Common Stock								11,119(1)	I	By Geoffrey S. Dow Revocable Trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Mr. Dow is the trustee of the Geoffrey S. Dow Revocable Trust, of which he is the trustee and has voting and dispositive control.

2. The reported transaction reflects an open-market purchase by the reporting person on September 12, 2025.

	/s/ Geoffrey Dow	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Geoffrey S. Dow report on Form 4 for SXTP?

The Form 4 reports an open-market acquisition of 7,201 shares of common stock on 09/12/2025 at a price of $1.3881 per share.

How many SXTP shares does Geoffrey S. Dow beneficially own after the reported transaction?

After the reported purchase, Mr. Dow directly beneficially owns 33,372 shares and indirectly beneficially owns 11,119 shares via the Geoffrey S. Dow Revocable Trust.

What is the nature of Mr. Dow's indirect ownership reported on the Form 4?

The indirect ownership is held through the Geoffrey S. Dow Revocable Trust, for which Mr. Dow is the trustee with voting and dispositive control.

Did the Form 4 report any derivative transactions or sales?

No. The filing only reports a non-derivative open-market purchase and contains no derivative transactions or dispositions.

When was the Form 4 signed by the reporting person?

The Form 4 bears the reporting person's signature dated 09/15/2025.